| Authors: |
Guermouche H; Institute of Medical Genetics, Lille University Hospital, Lille, France., Roynard P; Institute of Medical Genetics, Lille University Hospital, Lille, France., Servoli F; Institute of Medical Genetics, Lille University Hospital, Lille, France., Lestringant V; Department of Biological Hematology, Amiens-Picardie University Hospital, Amiens, France., Quilichini B; Eurofins-Biomnis Laboratory, Lyon, France., Terré C; Hematological Cytogenetics Laboratory, Versailles University Hospital, Le Chesnay, France., Defasque S; Hematological Cytogenetics Sector, Cerba Laboratory, Saint-Ouen l'Aumône, France., Roche-Lestienne C; Institute of Medical Genetics, Lille University Hospital, Lille, France; University Lille, Centre National de la Recherche Scientifique, Inserm, Lille University Hospital, Institut pour la Recherche sur le Cancer de Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France., Penther D; Oncogenetics, Henri Becquerel Center, Rouen, France., Daudignon A; Institute of Medical Genetics, Lille University Hospital, Lille, France; Hematology and Immunology Laboratory, Valenciennes University Hospital, Valenciennes, France. Electronic address: agnes.daudignon@chu-lille.fr. |
